大柴胡汤加味联合利拉鲁肽治疗肥胖2型糖尿病临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.1

基金项目:


Clinical Study on Modified Dachaihu Tang Combined with Liraglutide for Obese Type 2 Diabetes
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察大柴胡汤加味联合利拉鲁肽治疗肥胖2 型糖尿病的临床疗效及对超敏C-反应蛋白(hs-CRP) 的影响。方法:将104 例肥胖2 型糖尿病患者按随机数字表法分为观察组与对照组各52 例。对照组采用利拉鲁肽治疗,观察组在对照组基础上联合大柴胡汤治疗,比较2 组临床疗效、不良反应发生情况及治疗前后中医证候积分、炎症因子水平。结果:治疗后,观察组总有效率90.4%,高于对照组75.0% (P<0.05)。2 组治疗前血糖指标比较,差异无统计学意义(P>0.05),治疗后,2 组空腹血糖(FBG)、餐后2 h 血糖(P2hBG)、糖化血红蛋白(HbA1c) 降低,且观察组低于对照组(P<0.05)。与同组治疗前比较,治疗后2 组胃脘胀满、胸肋胀闷、心烦易怒、口干口苦、大便秘结、体型肥胖等中医证候积分均降低(P<0.05);与对照组治疗后比较,观察组治疗后以上各中医证候积分均较低(P<0.05)。与同组治疗前比较,治疗后2 组血清肿瘤坏死因子-α (TNF-α)、白细胞介素-6 (IL-6)、hs-CRP 水平均降低(P<0.05);与对照组治疗后比较,观察组治疗后血清TNF-α、IL-6、hs-CRP 水平均较低(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:大柴胡汤加味联合利拉鲁肽治疗肥胖2 型糖尿病临床效果较好,有助于改善患者临床症状,降低机体炎症因子水平,且安全性较高。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Dachaihu Tang combined with liraglutide for obese type 2 diabetes and its effects on high- sensitivity C- reactive protein(hs- CRP). Methods: A total of 104 cases of patients with obese type 2 diabetes were divided into the observation group and the control group according to the random number table method,with 52 cases in each group. The control group was treated with liraglutide,and the observation group was treated with Dachaihu Tang and liraglutide. The traditional Chinese medicine(TCM) syndrome scores and levels of inflammatory factors before and after treatment,clinical effects and the incidence of adverse reactions were compared between the two groups. Results: After treatment, the total effective rate was 90.4% in the observation group, higher than that of 75.0% in the control group(P<0.05). There was no significant difference in blood glucose indexes between the two groups before treatment(P>0.05). After treatment,fasting blood glucose(FBG), 2- hours postprandial blood glucose(P2hBG), glycosylated hemoglobin(HbA1c) in the two groups were decreased compared with those before treatment(P<0.05),and the indexes in the observation group were lower than those in the control group(P<0.05). After treatment, the TCM syndrome scores including epigastric fullness,chest rib distension,vexation and irascibility,dry mouth and bitter taste,constipation, and obesity in the two groups were decreased when compared with those before treatment(P<0.05);and each TCM syndrome score after treatment in the observation group was lower than that in the control group (P<0.05). After treatment,levels of tumor necrosis factor-α(TNF-α),interleukin-6(IL-6) and hs-CRP in serum in the two groups were decreased when compared with those before treatment(P<0.05),and the three levels in the observation group were lower than those in the control group(P<0.05). There was no statistically significant difference being found in the comparison of the incidence of adverse reactions between the two groups(P>0.05). Conclusion: Modified Dachaihu Tang combined with liraglutide has a good clinical effect in the treatment of obese type 2 diabetes,which helps to improve clinical symptoms and reduce levels of inflammatory factors in body with high safety.

    参考文献
    相似文献
    引证文献
引用本文

王正环,丁世芹,黄俊臣.大柴胡汤加味联合利拉鲁肽治疗肥胖2型糖尿病临床研究[J].新中医,2022,54(21):31-34

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-11-15
  • 出版日期: